176 related articles for article (PubMed ID: 34475101)
1. A Clinical PET Imaging Tracer ([
Beinat C; Patel CB; Haywood T; Murty S; Naya L; Castillo JB; Reyes ST; Phillips M; Buccino P; Shen B; Park JH; Koran MEI; Alam IS; James ML; Holley D; Halbert K; Gandhi H; He JQ; Granucci M; Johnson E; Liu DD; Uchida N; Sinha R; Chu P; Born DE; Warnock GI; Weissman I; Hayden-Gephart M; Khalighi M; Massoud TF; Iagaru A; Davidzon G; Thomas R; Nagpal S; Recht LD; Gambhir SS
Clin Cancer Res; 2021 Dec; 27(23):6467-6478. PubMed ID: 34475101
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
Beinat C; Patel CB; Xie Y; Gambhir SS
Mol Imaging Biol; 2020 Feb; 22(1):124-133. PubMed ID: 30989436
[TBL] [Abstract][Full Text] [Related]
3. Development of [
Beinat C; Alam IS; James ML; Srinivasan A; Gambhir SS
Mol Imaging Biol; 2017 Oct; 19(5):665-672. PubMed ID: 28236227
[TBL] [Abstract][Full Text] [Related]
4. The Utility of [
Beinat C; Haywood T; Chen YS; Patel CB; Alam IS; Murty S; Gambhir SS
Mol Imaging Biol; 2018 Dec; 20(6):1015-1024. PubMed ID: 29736561
[TBL] [Abstract][Full Text] [Related]
5. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [
Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS
Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711
[TBL] [Abstract][Full Text] [Related]
6. Human biodistribution and radiation dosimetry of [
Beinat C; Patel CB; Haywood T; Shen B; Naya L; Gandhi H; Holley D; Khalighi M; Iagaru A; Davidzon G; Gambhir SS
Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2123-2130. PubMed ID: 31938892
[TBL] [Abstract][Full Text] [Related]
7. Development of [
Kendirli MT; Malek R; Silveira MB; Acosta C; Zhang S; Azevedo C; Nagy SC; Habte F; James ML; Recht LD; Beinat C
Nucl Med Biol; 2023; 124-125():108382. PubMed ID: 37634399
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.
Witney TH; James ML; Shen B; Chang E; Pohling C; Arksey N; Hoehne A; Shuhendler A; Park JH; Bodapati D; Weber J; Gowrishankar G; Rao J; Chin FT; Gambhir SS
Sci Transl Med; 2015 Oct; 7(310):310ra169. PubMed ID: 26491079
[TBL] [Abstract][Full Text] [Related]
9. A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme.
Verma H; Cholia RP; Kaur S; Dhiman M; Mantha AK
Metab Brain Dis; 2021 Jun; 36(5):751-765. PubMed ID: 33651273
[TBL] [Abstract][Full Text] [Related]
10. N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.
Pagano C; Coppola L; Navarra G; Avilia G; Savarese B; Torelli G; Bruzzaniti S; Piemonte E; Galgani M; Laezza C; Bifulco M
FEBS Open Bio; 2024 May; 14(5):843-854. PubMed ID: 38514913
[TBL] [Abstract][Full Text] [Related]
11. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
Mukherjee J; Phillips JJ; Zheng S; Wiencke J; Ronen SM; Pieper RO
PLoS One; 2013; 8(2):e57610. PubMed ID: 23451252
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma PET/MRI: kinetic investigation of [
Lindemann M; Oteiza A; Martin-Armas M; Guttormsen Y; Moldes-Anaya A; Berzaghi R; Bogsrud TV; Bach-Gansmo T; Sundset R; Kranz M
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1183-1194. PubMed ID: 36416908
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Glioblastoma Multiforme Cell Circuits with Cinnamaldehyde Highlights Potential Targets with Implications for Novel Therapeutic Strategies.
Srivastava S; Patil K; Thompson EW; Nakhai SA; Kim YN; Haynes C; Bryant C; Pai SB
Cells; 2023 Apr; 12(9):. PubMed ID: 37174677
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
Yavuz BB; Kilinc F; Kanyilmaz G; Aktan M
J Neurooncol; 2023 Dec; 165(3):527-533. PubMed ID: 38010491
[TBL] [Abstract][Full Text] [Related]
19. Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis.
Guo J; Xue Q; Liu K; Ge W; Liu W; Wang J; Zhang M; Li QY; Cai D; Shan C; Zhang C; Liu X; Li J
Front Oncol; 2019; 9():993. PubMed ID: 31632919
[TBL] [Abstract][Full Text] [Related]
20. M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance.
Bailleul J; Ruan Y; Abdulrahman L; Scott AJ; Yazal T; Sung D; Park K; Hoang H; Nathaniel J; Chu FI; Palomera D; Sehgal A; Tsang JE; Nathanson DA; Xu S; Park JO; Ten Hoeve J; Bhat K; Qi N; Kornblum HI; Schaue D; McBride WH; Lyssiotis CA; Wahl DR; Vlashi E
Neuro Oncol; 2023 Nov; 25(11):1989-2000. PubMed ID: 37279645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
